Free Trial
→ Elon just did WHAT!? (From Brownstone Research) (Ad) Buy PHVS Stock  Free PHVS Stock Alerts

Pharvaris (PHVS) Financials

Pharvaris logo
$16.72 +1.26 (+8.15%)
Closing price 04:00 PM Eastern
Extended Trading
$16.71 -0.01 (-0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Pharvaris

Annual Income Statements for Pharvaris

This table shows Pharvaris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Net Income / (Loss) Attributable to Common Shareholders		 -139 -112 -82 -48 -32 -9.01 -4.94
Consolidated Net Income / (Loss)		 -139 -112 -82 -48 -32 -9.01 -4.94
Net Income / (Loss) Continuing Operations		 -139 -112 -82 -48 -32 -9.01 -4.94
Total Pre-Tax Income 		-137 -110 -81 -48 -32 -9.01 -4.94
Total Operating Income		 -137 -110 -81 -48 -32 -8.99 -4.94
Total Gross Profit		 14 -3.22 12 13 -1.30 0.00 -0.00
Total Revenue		 14 -3.22 12 13 -1.30 0.00 0.00
Operating Revenue		 14 -3.22 12 13 -1.30 - -
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 151 107 93 61 31 8.99 4.94
Selling, General & Admin Expense		 49 35 31 21 6.72 2.61 0.76
Research & Development Expense		 102 73 61 41 24 6.38 4.17
Total Other Income / (Expense), net		 0.00 0.00 0.00 0.00 0.00 -0.02 0.00
Income Tax Expense		 1.89 1.16 0.73 0.08 -0.10 0.00 0.00
Basic Earnings per Share		 ($2.57) ($2.63) ($2.27) ($1.40) ($5.36) - ($0.89)
Weighted Average Basic Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M - -
Diluted Earnings per Share		 ($2.57) ($2.63) ($2.27) ($1.40) ($5.36) - ($0.89)
Weighted Average Diluted Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M - -
Weighted Average Basic & Diluted Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M - -

Quarterly Income Statements for Pharvaris

No quarterly income statements for Pharvaris are available.

Annual Cash Flow Statements for Pharvaris

This table details how cash moves in and out of Pharvaris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Net Change in Cash & Equivalents		 -122 257 -63 112 97 17 0.68
Net Cash From Operating Activities		 -124 -103 -72 -50 -26 -7.49 -4.48
Net Cash From Continuing Operating Activities		 -129 -102 -79 -50 -29 -8.81 -4.66
Net Income / (Loss) Continuing Operations		 -137 -110 -81 -48 -32 -9.01 -4.94
Consolidated Net Income / (Loss)		 -137 -110 -81 -48 -32 -9.01 -4.94
Depreciation Expense		 0.28 0.28 0.16 0.09 0.01 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income		 6.33 14 0.11 -4.07 3.71 0.13 0.12
Changes in Operating Assets and Liabilities, net		 1.53 -5.72 1.83 2.01 -0.64 0.07 0.15
Net Cash From Investing Activities		 -0.56 -0.10 -0.13 -0.15 -0.05 -0.02 0.00
Net Cash From Continuing Investing Activities		 -0.56 -0.10 -0.13 -0.15 -0.05 -0.02 0.00
Purchase of Property, Plant & Equipment		 -0.56 -0.10 -0.13 -0.15 -0.05 -0.02 0.00
Net Cash From Financing Activities		 2.77 360 9.25 163 124 24 5.16
Net Cash From Continuing Financing Activities		 -0.17 -19 -1.03 -15 124 24 5.16
Repayment of Debt		 -0.17 -0.24 -0.13 0.00 0.00 - -

Quarterly Cash Flow Statements for Pharvaris

No quarterly cash flow statements for Pharvaris are available.

Annual Balance Sheets for Pharvaris

This table presents Pharvaris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Total Assets		 302 441 179 240 124 23
Total Current Assets		 300 440 178 239 123 23
Cash & Equivalents		 291 433 173 237 120 23
Current Deferred & Refundable Income Taxes		 3.05 1.15 0.41 - - -
Other Current Assets		 5.95 6.17 4.95 1.71 2.14 0.05
Plant, Property, & Equipment, net		 0.69 0.25 0.21 0.12 0.06 0.01
Plant, Property & Equipment, gross		 0.69 0.25 0.21 0.12 0.06 0.01
Total Noncurrent Assets		 1.33 0.69 0.74 0.47 0.00 0.00
Noncurrent Deferred & Refundable Income Taxes		 0.49 0.43 0.28 0.19 - -
Other Noncurrent Operating Assets		 0.84 0.26 0.46 0.28 0.00 -
Total Liabilities & Shareholders' Equity		 302 441 179 240 124 23
Total Liabilities		 24 16 20 8.08 6.49 2.16
Total Current Liabilities		 23 16 19 7.76 6.47 2.16
Accounts Payable		 4.72 3.22 7.15 2.82 1.01 0.58
Accrued Expenses		 18 12 12 4.83 5.46 1.58
Other Current Liabilities		 0.23 0.22 0.20 0.11 0.00 -
Total Noncurrent Liabilities		 0.66 0.05 0.27 0.17 0.00 0.00
Capital Lease Obligations		 0.66 0.05 0.27 0.17 - -
Total Equity & Noncontrolling Interests		 277 425 160 232 117 21
Total Preferred & Common Equity		 277 425 160 232 117 21
Preferred Stock		 646 681 309 315 169 41
Total Common Equity		 -368 -256 -150 -84 -52 -20
Common Stock		 6.75 6.94 4.34 4.50 0.29 0.15
Retained Earnings		 -416 -294 -176 -99 -54 -21
Other Equity Adjustments		 41 31 22 11 2.41 0.44

Quarterly Balance Sheets for Pharvaris

No quarterly balance sheets for Pharvaris are available.

Annual Metrics And Ratios for Pharvaris

This table displays calculated financial ratios and metrics derived from Pharvaris' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Growth Metrics		 - - - - - - -
Revenue Growth		 527.01% -127.23% -8.91% 1,100.99% 0.00% 0.00% 0.00%
EBITDA Growth		 -24.17% -36.37% -67.59% -51.38% -253.43% -82.45% 0.00%
EBIT Growth		 -24.10% -36.44% -67.62% -51.62% -253.51% -82.46% 0.00%
NOPAT Growth		 -24.10% -36.44% -67.62% -51.62% -254.25% -82.07% 0.00%
Net Income Growth		 -24.51% -36.65% -68.85% -52.35% -252.38% -82.46% 0.00%
EPS Growth		 11.77% -15.86% -62.14% 73.88% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -20.81% -43.26% -42.34% -92.19% -250.50% -67.08% 0.00%
Free Cash Flow Firm Growth		 -10.46% -69.82% -48.67% -58.98% -363.57% 0.00% 0.00%
Invested Capital Growth		 -63.54% 41.54% -172.06% -30.54% -92.72% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - -
Gross Margin		 100.00% 0.00% 100.00% 100.00% 0.00% 0.00% 0.00%
EBITDA Margin		 -994.06% 0.00% -682.57% -371.00% 0.00% 0.00% 0.00%
Operating Margin		 -996.09% 0.00% -683.96% -371.67% 0.00% 0.00% 0.00%
EBIT Margin		 -996.09% 0.00% -683.96% -371.67% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 -1,009.82% 0.00% -690.10% -372.29% 0.00% 0.00% 0.00%
Tax Burden Percent		 101.38% 101.05% 100.90% 100.16% 99.68% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -39.58% -38.18% -41.70% -27.72% -46.02% -42.99% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -36.91% 0.00% -38.59% -26.56% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 -37.42% 0.00% -38.93% -26.61% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 35.23% 26.52% 24.83% 10.73% 23.93% 41.32% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -50.13% -26.27% -51.14% -20.85% -27.13% -42.99% 0.00%
Net Operating Profit after Tax (NOPAT)		 -96 -77 -57 -34 -22 -6.29 -3.46
NOPAT Margin		 -697.26% 0.00% -478.77% -260.17% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -11.92% -11.34% -12.23% -8.15% -13.18% -23.81% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -34.53% - - - - - -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 354.54% 0.00% 265.24% 159.87% 0.00% 0.00% 0.00%
R&D to Revenue		 741.54% 0.00% 518.71% 311.81% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 1,096.09% 0.00% 783.96% 471.67% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -137 -110 -81 -48 -32 -9.01 -4.94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -137 -110 -81 -48 -32 -9.01 -4.94
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 72.86 0.00 31.52 5.37 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 98.71 0.00 43.05 11.43 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.03 -1.03 -1.04 -1.02 -1.04 -1.09 0.00
Leverage Ratio		 1.06 1.06 1.07 1.04 1.06 1.10 0.00
Compound Leverage Factor		 1.06 1.06 1.07 1.04 1.06 1.10 0.00
Debt to Total Capital		 0.24% 0.01% 0.17% 0.07% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.24% 0.01% 0.17% 0.07% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 232.36% 160.33% 193.42% 135.90% 144.11% 196.13% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -132.59% -60.34% -93.59% -35.98% -44.11% -96.13% 0.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 2.12 3.93 2.14 4.91 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00
Net Debt to NOPAT		 3.02 5.60 3.05 7.01 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00
Altman Z-Score		 22.32 34.52 9.60 5.15 14.95 44.51 0.00
Noncontrolling Interest Sharing Ratio		 189.00% 169.47% 159.54% 138.72% 152.01% 196.13% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 12.94 28.07 9.39 30.84 19.06 10.70 0.00
Quick Ratio		 12.55 27.60 9.11 30.62 18.72 10.67 0.00
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 -91 -83 -49 -33 -21 -4.44 0.00
Operating Cash Flow to CapEx		 -22,325.46% -103,406.58% -54,034.37% -34,299.06% -50,025.73% -49,546.04% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.04 0.00 0.06 0.07 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 17.46 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 29.34 0.00 71.86 143.07 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 20.91 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 20.91 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 -12 -7.42 -13 -4.67 -3.57 -1.85 0.00
Invested Capital Turnover		 -1.41 0.00 -1.36 -3.15 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -4.72 5.27 -8.03 -1.09 -1.72 -1.85 0.00
Enterprise Value (EV)		 1,358 1,197 509 148 214 184 0.00
Market Capitalization		 1,002 949 373 70 165 165 165
Book Value per Share		 ($7.04) ($7.58) ($4.52) ($17.22) ($10.64) ($2.44) $0.00
Tangible Book Value per Share		 ($7.04) ($7.58) ($4.52) ($17.22) ($10.64) ($2.44) $0.00
Total Capital		 278 425 160 232 117 21 0.00
Total Debt		 0.66 0.05 0.27 0.17 0.00 0.00 0.00
Total Long-Term Debt		 0.66 0.05 0.27 0.17 0.00 0.00 0.00
Net Debt		 -290 -433 -173 -237 -120 -23 0.00
Capital Expenditures (CapEx)		 0.56 0.10 0.13 0.15 0.05 0.02 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -14 -8.35 -14 -5.26 -3.63 -1.87 0.00
Debt-free Net Working Capital (DFNWC)		 276 424 159 232 117 21 0.00
Net Working Capital (NWC)		 276 424 159 232 117 21 0.00
Net Nonoperating Expense (NNE)		 43 34 25 15 9.45 2.72 1.48
Net Nonoperating Obligations (NNO)		 -289 -432 -172 -237 -121 -23 0.00
Total Depreciation and Amortization (D&A)		 0.28 0.28 0.16 0.09 0.01 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -102.94% 0.00% -115.30% -40.48% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 2,009.12% 0.00% 1,347.81% 1,783.47% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 2,009.12% 0.00% 1,347.81% 1,783.47% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 ($2.57) ($2.63) ($2.27) $0.00 ($5.36) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M 0.00 0.00
Adjusted Diluted Earnings per Share		 ($2.57) ($2.63) ($2.27) $0.00 ($5.36) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($2.27) $0.00 ($5.36) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 54.38M 52.29M 33.82M 33.15M 4.85M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -96 -77 -57 -34 -22 -6.29 -3.46
Normalized NOPAT Margin		 -697.26% 0.00% -478.77% -260.17% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 -996.09% 0.00% -683.96% -371.67% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -17.15% -1.10% -30.78% -5.06% -10.42% 0.00%

Quarterly Metrics And Ratios for Pharvaris

No quarterly metrics and ratios for Pharvaris are available.

Frequently Asked Questions About Pharvaris' Financials

When does Pharvaris's financial year end?

According to the most recent income statement we have on file, Pharvaris' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Pharvaris' net income changed over the last 6 years?

Pharvaris' net income appears to be on an upward trend, with a most recent value of -$138.93 million in 2024, rising from -$4.94 million in 2018. The previous period was -$111.59 million in 2023. See Pharvaris' forecast for analyst expectations on what’s next for the company.

What is Pharvaris's operating income?
Pharvaris's total operating income in 2024 was -$137.04 million, based on the following breakdown:
  • Total Gross Profit: $13.76 million
  • Total Operating Expenses: $150.80 million
How has Pharvaris revenue changed over the last 6 years?

Over the last 6 years, Pharvaris' total revenue changed from $0.00 in 2018 to $13.76 million in 2024, a change of 1,375,820,100.0%.

How much debt does Pharvaris have?

Pharvaris' total liabilities were at $24.44 million at the end of 2024, a 50.9% increase from 2023, and a 1,031.9% increase since 2019.

How much cash does Pharvaris have?

In the past 5 years, Pharvaris' cash and equivalents has ranged from $22.81 million in 2019 to $432.78 million in 2023, and is currently $290.58 million as of their latest financial filing in 2024.

How has Pharvaris' book value per share changed over the last 6 years?

Over the last 6 years, Pharvaris' book value per share changed from 0.00 in 2018 to -7.04 in 2024, a change of -704.5%.


Related Companies

This page (NASDAQ:PHVS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
As Bitcoin supply vanishes, this Trump-aligned token could explode
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...
Brownstone Research | Sponsored